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Angiopoietin-2, marker and mediator of endothelial activation
with prognostic significance early after trauma
Abstract
OBJECTIVE: To measure plasma levels of angiopoietin-1 (Ang-1), angiopoietin-2 (Ang-2), and
vascular endothelial growth factor (VEGF) early after trauma and to determine their clinical
significance. BACKGROUND: Angiopoietins and VEGF play a central role in the physiology and
pathophysiology of endothelial cells. Ang-2 has recently been shown to have pathogenetic significance
in sepsis and acute lung injury. Little is known about the role of angiopoietins and VEGF early after
trauma. METHODS: Blood specimens from consecutive major trauma patients were obtained
immediately upon arrival in the emergency department and plasma samples assayed for Ang-1, Ang-2,
VEGF, markers of endothelial activation, protein C pathway, fibrinolytic system, and complement. Base
deficit was used as a measure of tissue hypoperfusion. Data were collected prospectively. RESULTS:
Blood samples were obtained from 208 adult trauma patients within 30 minutes after injury before any
significant fluid resuscitation. Plasma levels of Ang-2, but not Ang-1 and VEGF were increased and
correlated independently with severity of injury and tissue hypoperfusion. Furthermore, plasma levels of
Ang-2 correlated with markers of endothelial activation, coagulation abnormalities, and activation of the
complement cascade and were associated with worse clinical outcome. CONCLUSIONS: Ang-2 is
released early after trauma with the degree proportional to both injury severity and systemic
hypoperfusion. High levels of Ang-2 were associated with an activated endothelium, coagulation
abnormalities, complement activation, and worse clinical outcome. These data indicate that Ang-2 is a
marker and possibly a direct mediator of endothelial activation and dysfunction after severe trauma.
 1
 
Angiopoietin-2, Marker and Mediator of Endothelial Activation 
with Prognostic Significance Early after Trauma ? 
 
Michael T. Ganter MD*, Mitchell J. Cohen MD*, Karim Brohi FRCS FRCA, Brian B. 
Chesebro MD, Kristan L. Staudenmayer MD, Pamela Rahn BS, Sarah C. Christiaans 
BS, Natasha D. Bir MD, Jean-François Pittet MD 
* These authors contributed equally to this work 
Author affiliations: The Departments of Anesthesia (Ganter, Chesebro, Christiaans & 
Pittet) and Surgery (Cohen, Staudenmayer, Rahn, Bir & Pittet), San Francisco General 
Hospital, University of California San Francisco, CA and The Royal London Hospital, 
London, UK (Brohi) 
 
Institution at which work was performed: The Departments of Anesthesia and Surgery at 
San Francisco General Hospital, University of California San Francisco, CA 
 
Corresponding author: Michael T. Ganter, MD 
Department of Anesthesia, San Francisco General Hospital 
1001 Potrero Avenue, Room 3C-38 
San Francisco, CA 94110 
Phone: (415) 206-8163; Fax: (415) 206-6014 
Email: mt.ganter@gmail.com  
 
Running Head: Angiopoietin-2 early after trauma 
 2
 
MINI-ABSTRACT 
Plasma levels of endothelial cell specific growth factors, Angiopoietin-1 (Ang-1), 
Angiopoietin-2 (Ang-2) and vascular endothelial growth factor (VEGF) were measured 
immediately after trauma in 208 consecutive adult trauma patients. Levels of Ang-2, but 
not Ang-1 and VEGF correlated with injury severity, hypoperfusion, endothelial 
activation, coagulation abnormalities, inflammation and worse clinical outcome. 
 
STRUCTURED ABSTRACT 
Objective: 
To measure plasma levels of Angiopoietin-1 (Ang-1), Angiopoietin-2 (Ang-2) and 
vascular endothelial growth factor (VEGF) early after trauma and to determine their 
clinical significance. 
Background: 
Angiopoietins and VEGF play a central role in the physiology and pathophysiology of 
endothelial cells. Ang-2 has recently been shown to have pathogenetic significance in 
sepsis and acute lung injury. Little is known about the role of angiopoietins and VEGF 
early after trauma. 
Methods: 
Blood specimens from consecutive major trauma patients were obtained immediately 
upon arrival in the emergency department and plasma samples assayed for Ang-1, Ang-
2, VEGF, markers of endothelial activation, protein C pathway, fibrinolytic system and 
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complement. Base deficit was used as a measure of tissue hypoperfusion. Data were 
collected prospectively. 
Results: 
Blood samples were obtained from 208 adult trauma patients within 30 min after injury 
prior to any significant fluid resuscitation. Plasma levels of Ang-2, but not Ang-1 and 
VEGF were increased and correlated independently with severity of injury and tissue 
hypoperfusion. Furthermore, plasma levels of Ang-2 correlated with markers of 
endothelial activation, coagulation abnormalities, activation of the complement cascade 
and were associated with worse clinical outcome. 
Conclusions: 
Ang-2 is released early after trauma with the degree proportional to both injury severity 
and systemic hypoperfusion. High levels of Ang-2 were associated with an activated 
endothelium, coagulation abnormalities, complement activation and worse clinical 
outcome. This data indicate that Ang-2 is a marker and possibly a direct mediator of 
endothelial activation and dysfunction after severe trauma. 
 
 4
 
INTRODUCTION 
Trauma accounts for a significant proportion of death and disabilities worldwide and it 
is expected that trauma-related mortality will increase in the near future.1 Uncontrollable 
hemorrhage and severe central nervous system injury are responsible for the majority of 
trauma-related death in the first 24 hours. After this initial period, critical care 
complications such as multi-organ failure replace hemorrhage as a major cause of 
trauma-related death.2 Endothelial activation and dysfunction has been shown to play a 
major role in the development of organ injuries thereby representing an independent 
parameter for worse clinical outcome in critically ill patients.3-6 
Angiopoietins and vascular endothelial growth factor (VEGF) are growth factors that 
have been shown to play an important role in the development, physiology and 
pathophysiology of endothelial cells.7 Angiopoietin-1 (Ang-1) activates the endothelial 
Tie-2 receptor thereby maintaining a quiescent resting state of the endothelium. On the 
other side, Angiopoietin-2 (Ang-2) binds to the same site of the Tie-2 receptor but 
functions as an antagonist ligand of Tie-2.8 Therefore, Ang-2 has been shown to 
destabilize blood vessels, to enhance vascular leakage, to induce vascular regression 
and to prime the endothelium to respond to VEGF and other angiogenetic and 
inflammatory cytokines.9 Because Ang-1 and Ang-2 have agonist-antagonist properties 
on the endothelium, it has been proposed to determine the ratio between Ang-1 and 
Ang-2 to better describe the state of activation of the endothelium.10 Like von Willebrand 
factor (vWF), Ang-2 is stored in endothelial cell specific storage granules (Weibel-Palade 
bodies) and rapidly released upon stimulation of the endothelium, serving as a potential 
marker of endothelial activation and dysfunction.11 It has been recently shown that 
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plasma levels of Ang-2 are increased in patients with sepsis12,13 and that Ang-2 plays an 
important pathogenetic role in acute lung injury.14 However, little is known about the role 
of angiopoietins and VEGF in the early phase after trauma in humans.  
The first aim of the present study was to measure plasma levels of Ang-1, Ang-2 and 
VEGF in a large number of trauma patients immediately after injury. We found that only 
Ang-2 is released early after trauma in degree proportional to both injury severity and 
global hypoperfusion. Levels of Ang-2 correlated with vWF and sTM, indicating that Ang-
2 might be a marker of endothelial activation and dysfunction in trauma patients. It has 
been previously reported that thrombin15 and hypoxia16,17 induce the extracellular 
release of Ang-2 by endothelial cells. Furthermore, we have previously shown early after 
trauma in humans that systemic hypoperfusion is associated with a coagulopathy 
associated with an activation of the protein C pathway and the complement cascade.18,19 
Thus, the second aim of this study was to determine whether elevated plasma levels of 
Ang-2 were associated with the development of coagulopathy and complement 
activation early after severe trauma. The third aim was then to identify the prognostic 
significance of Ang-2, in particular its relationship to the development of organ failure 
and clinical outcome after severe trauma.  
 
METHODS 
The Institutional Review Board of the University of California at San Francisco 
approved the research protocol for this prospective cohort study and granted a waiver of 
consent for the blood sampling as a minimal risk intervention.  
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Patients 
Consecutive major trauma patients admitted to the San Francisco General Hospital 
(level 1 trauma center) were studied. All adult trauma patients who met criteria for full 
trauma team activation were eligible for enrollment. Patients less than 18 years old or 
transferred from other hospitals were immediately excluded.  
Sample collection and measurement 
The methodology has been described previously in detail.18,19 Briefly, a 10 ml 
research sample of blood was drawn in citrated tubes within 10 minutes of arrival in the 
emergency department. The samples were immediately transferred to the central 
laboratory, centrifuged and the plasma extracted and stored at -80°C. In this study, we 
measured Angiopoietin-1 (Ang-1; Quantikine Ang-2 EIA, R&D Systems Inc., 
Minneapolis, MN), Angiopoietin-2 (Ang-2; Quantikine Ang-2 EIA, R&D Systems Inc., 
Minneapolis, MN), vascular endothelial growth factor (VEGF; Quantikine VEGF EIA, 
R&D Systems Inc., Minneapolis, MN), von Willebrand Factor Antigen (vWF; 
Asserachrom vWF, Diagnostica Stago Inc., Asniere, France), IL-6 and IL-10 (R&D 
Systems Inc., Minneapolis, MN) in addition to previously measured levels of the 
anticoagulatory thrombomodulin-protein C pathway (soluble thrombomodulin [sTM], 
protein C), fibrinolytic system (tissue plasminogen activator [t-PA], plasminogen activator 
inhibitor-1 [PAI-1], D-Dimers) and the complement cascade (Bb fragments, soluble C5b-
9).18,19 The normal value of Ang-2 was 641-2755 pg/ml and determined by testing 10 
randomly selected healthy volunteers. All measurements were done in accordance with 
the manufacturer’s instructions. 
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Data collection, outcome measures 
Data were collected prospectively on patient demographics, the injury time, 
mechanism (blunt or penetrating) and severity, pre-hospital fluid administration, time of 
arrival in the trauma room and admission vital signs. The Injury Severity Score (ISS) was 
used as a measure of the degree of tissue injury.20 An arterial blood gas was drawn at 
the same time as the research sample as part of the standard management of major 
trauma patients. The base deficit was used as a measure of the degree of tissue 
hypoperfusion. Admission base deficit is a clinically useful early marker of tissue 
hypoperfusion in trauma patients and an admission base deficit greater than 6 mmol/l 
has previously been identified as predictive of worse outcome in trauma patients.21,22  
Outcome measures: Patients were followed until hospital discharge or death. For 
mortality analysis, patients surviving to hospital discharge were assumed to still be alive. 
Secondary outcome measures were also recorded for 28-day ventilator-free days, acute 
lung injury (American-European consensus conference definition23) and acute renal 
injury (Acute Dialysis Quality Initiative consensus conference definition24) and blood 
transfusions required in the first 24 hours. 
Statistical analysis 
Data analysis was performed by the investigators. Normal-quantile plots were used 
to test for normal distribution. Parametric data are expressed as mean ± 95% confidence 
intervals. Two-group analysis was performed with a two-tailed unequal variance 
Student’s t-test. Correlation was assessed by Pearson’s method and multiple regression 
was used to test for statistical independence. The χ test was used for dichotomous data 
analysis. A p-value of ≤ 0.05 was chosen to represent statistical significance. 
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RESULTS 
Over a 15 month period, we enrolled 208 consecutive traumatized patients into the 
study. Median time from injury to blood sampling was 32 minutes, there was no 
vasopressor or colloid administration and patients received an average of 150 ± 100 ml 
of intravenous crystalloid prior to the blood specimen collection. Clinical characteristics 
of our severely injured patients are shown in Table 1. 
Plasma levels of Ang-2, but not Ang-1 and VEGF were increased immediately after 
trauma and correlated with severity of injury as measured by Injury Severity Score 
(Figure 1A-C). Interestingly, female patients (n=53) had significantly higher plasma 
levels of Ang-2 than male patients (n=156) (3198±529 vs. 2570±284 pg/ml, p < 0.05). 
Similarly, blunt trauma patients had also significantly higher plasma levels of Ang-2 than 
penetrating trauma patients (2894±327 vs. 2245±217 pg/ml, p < 0.05). These 
differences are likely explained by the fact that both female patients and blunt trauma 
patients had significantly higher ISS than respectively male patients and penetrating 
trauma patients (female vs. male patients: 21.7±3.4 vs. 17.0±2.0, p < 0.05; blunt vs. 
penetrating trauma patients: 20.0±2.1 vs. 12.9±2.6, p < 0.05). Finally, the presence of 
head injury did not influence plasma levels of Ang-2 in our cohort of trauma patients 
(data not shown).  
Ang-2 is stored in the same endothelial organelles like vWF (Weibel Palade bodies) 
and released in part by the same mechanism upon endothelial stimulation.11 We 
therefore hypothesized that Ang-2 could be a marker of endothelial activation and 
dysfunction in trauma patients and compared Ang-2 plasma levels with those of vWF 
and sTM, known markers of endothelial activation.25 Plasma levels of vWF (Figure 1D) 
and sTM (sTM: ISS <9: 35±4, ISS >25: 46±9 ng/ml, p = 0.03 – upper-lower quartile 
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comparison) were increased in patients with severe trauma and correlated with Ang-2 
(Figure 2).  
Hemorrhagic shock per se has been shown to compromise the endothelial cell 
function.26 Furthermore, hypoxia induces the release of Ang-2 from endothelial cells.16,17 
We therefore examined the effects of systemic hypoperfusion on the release of 
endothelial cell specific growth factors and endothelial activation. Patients with a base 
deficit >7.6 had significantly higher plasma levels of Ang-2, vWF (Figure 3A,D) and sTM 
(BD <2.2: 35±3, BD >7.6: 57±15 ng/ml, p = 0.01 – upper-lower quartile comparison) 
compared to those with no base deficit (<2.2). In contrast, plasma levels of Ang-1 and 
VEGF (Figure 3B,C) were not affected by systemic hypoperfusion seen early after 
trauma. Furthermore, multiple regression analysis identified that the effects of injury 
severity and tissue hypoperfusion on the release of Ang-2 were statistically independent 
(r2 = 0.17; ISS p < 0.001; BD p = 0.01). 
Coagulation abnormalities are common following major trauma and are directly 
related to worse clinical outcome.27 We have recently shown that only patients who are 
severely injured and in shock are coagulopathic early after injury and that this is due to 
activation of the protein C pathway rather than consumption of coagulation factors.18 We 
next thought to identify whether the release of Ang-2 in our patients was related to 
coagulation abnormalities. Patients with coagulation abnormalities (PT >15.2 sec, PTT 
>36.5 sec) had significantly higher levels of Ang-2 (Figure 4A). Increasing Ang-2 was 
associated with a rise in the levels of soluble thrombomodulin (Figure 2B) and a fall in 
protein C levels (Figure 4B), suggesting activation of the anticoagulant protein C 
pathway in patients with increased endothelial activation. Furthermore, levels of Ang-2 
were positively correlated with d-dimer levels (Figure 4C), suggesting an increased 
 10
 
fibrinolytic activity in patients with endothelial activation. This finding was supported by 
measuring t-PA and PAI-1 levels: there was a significant positive and inverse correlation 
between t-PA and Ang-2 as well as PAI-1 and Ang-2, respectively (data not shown).  
We have previously found in patients with severe trauma that activation of the 
complement system, particularly its alternative pathway, is related to increased rate of 
organ injuries and mortality.19 To examine if endothelial cell specific growth factors are 
associated with the early inflammatory response in trauma, we measured Bb fragments, 
a marker of the activation of the alternative complement pathway and soluble C5b-9 
(membrane attack complex), generated during the late phase of complement activation. 
Again, we found that levels of Ang-2, not Ang-1 or VEGF correlated with those of Bb and 
soluble C5b-9 (Figure 5A,B). Finally, we measured the plasma levels of two cytokines 
(IL-6 and IL10) that have been shown to be respectively markers of systemic 
inflammation and anti-inflammatory response. We found that that the plasma levels of 
both pro- and anti-inflammatory cytokines were significantly higher in trauma patients 
with hypoperfusion (base deficit greater than 6 mmol/l) compared to those without 
hypoperfusion (IL-6: 59.9 ± 3.9 vs 27.1 ± 1.0 pg/ml, p < 0.05; IL-10: 89.3 ± 6.9 vs 37.1 ± 
0.9 pg/ml, p < 0.05).  
Finally, to determine the clinical significance of these findings, we examined whether 
early Ang-2 release was associated with worse clinical outcome (Table 2). We found 
that there was a direct correlation between mortality rate and plasma levels of Ang-2 
(Figure 6A). Non-survivors (n=26) had significantly higher plasma levels of Ang-2 
compared to survivors (n=183) (4355±1426 vs. 2494±186 pg/ml, p < 0.001) (Figure 6B). 
Patients who later developed organ injury had significantly higher plasma levels of Ang-
2. Acute renal failure was present in 5% in patients with normal Ang-2 levels but 28% of 
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those with high Ang-2 (p < 0.001). There was also a trend toward increased incidence of 
acute lung injury with elevated Ang-2 levels (19% vs. 11%, p = 0.09). High levels of Ang-
2 were also associated with fewer ventilator-free days and increased blood transfusion 
requirements (Table 2). 
 
DISCUSSION 
The present study shows that Ang-2 is released within 30 min after trauma in 
patients with severe injury and systemic hypoperfusion. Levels of Ang-2 correlated with 
markers of endothelial activation. Furthermore, high levels of Ang-2 were associated 
with early coagulation abnormalities, complement activation and worse clinical outcome. 
This data indicate that Ang-2 is a marker and possibly a direct mediator of endothelial 
activation and dysfunction after severe trauma. 
The first major finding of the present study is to demonstrate that Ang-2, but not Ang-
1 and VEGF is increased in the plasma of patients early after trauma. The endothelial 
barrier is tightly regulated by angiopoietins.28 Ang-1 and Ang-2 are the best 
characterized angiopoietins of the four currently known and bind to Tie-2 receptors 
(tyrosine kinase with immunoglobulin-like loop and epidermal growth factor homology 
domain), mostly expressed on endothelial cells.29 Ang-1 is an agonist at the Tie-2 
receptor, thereby controlling endothelial cell survival and vessel maturation and exerting 
anti-permeability and anti-inflammatory functions. In contrast, Ang-2 is a Tie-2 receptor 
antagonist blocking the Ang-1/Tie-2 signaling acting as a blood vessel destabilizing 
cytokine and disrupting the endothelial barrier.12,30,31 Profiling studies have demonstrated 
that endothelial cells are the primary source of Ang-2.32 Because Ang-1 and Ang-2 have 
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agonist-antagonist properties on the endothelium, it has been proposed to determine the 
ratio between Ang-1 and Ang-2 rather than the absolute levels of either ligand.10 Our 
trauma patients with severe injury and shock had high plasma levels of Ang-2 but 
unchanged levels of Ang-1, i.e. a low Ang-1/Ang-2 ratio when compared with patients 
with minor or no injury indicating that these patients have an activated endothelial cell 
phenotype early after injury.  
Endothelial activation and dysfunction occurs early after trauma hemorrhage.26 To 
assess the endothelial integrity, measurement of different endothelial-related markers 
with different characteristics like vWF and sTM have been proposed.25 Pre-made vWF 
and Ang-2 protein is typically stored in Weibel-Palade bodies (subcellular organelles) 
together with other proteins allowing the endothelium to immediately release these 
mediators upon stimulation.11 The exocytosis of Weibel-Palade bodies can be induced 
by multiple factors like hypoxia,16,17 oxidative stress,33 thrombin,34 complement35 and 
VEGF36 – many of those being present in severely injured patients. Furthermore, we and 
others have previously reported that on admission to the hospital, increased plasma 
levels of sTM are observed in trauma patients with hypoperfusion and acidosis.3,18 
Thrombomodulin (TM) is a cell surface glycoprotein that complexes thrombin, thereby 
converting protein C to activated protein C. Several mechanisms like oxidative stress 
and proteolytic cleavage by activated leukocytes have been proposed by which TM is 
being shed from the cell surface indicating that sTM is another marker for endothelial 
activation and dysfunction.37 Here we reported that the increase in plasma levels of Ang-
2 correlated with those of vWF and sTM indicating that Ang-2 is a marker of endothelial 
activation and dysfunction in trauma patients. 
 13
 
VEGF is another endothelial cell specific growth factor and considered a key 
mediator in the control of vascular permeability acting in concert with angiopoietins.38 
Several studies measured VEGF levels in animals and humans and reported some 
controversial findings. For example, plasma levels of VEGF have been shown to be 
increased in septic patients and were related to disease severity and mortality.39,40 In 
contrast in the present study, plasma VEGF levels measured 30 min after injury were 
unrelated to injury severity, systemic hypoperfusion and patient outcome. This finding is 
in accordance with previously published studies on trauma and burn patients where 
VEGF levels on admission were unrelated to the extent of the initial injury and not 
different from a healthy control group.41,42 However, it may be premature to conclude 
that VEGF cell signaling is not activated in the early post-injury period. As shown 
previously in rat models of ischemia and reperfusion (I/R), VEGF cell signaling has been 
implicated in the I/R injury in the lung43 and kidney44 without any increase in VEGF 
protein release or expression.  
Clinical significance. High levels of circulating Ang-2 have been recently reported in 
critical care patients with acute lung injury and sepsis, clinical situations associated with 
increased vascular leakage.12-14 Orfanos et al. reported in 61 septic patients that levels 
of Ang-2 correlated with the intensity of the inflammatory response and disease 
severity.13 Another study on 22 septic patients with acute lung injury by Parikh et al. 
showed a correlation of Ang-2 with impaired pulmonary gas exchange.12 The present 
study is the first to report that plasma levels of Ang-2 on admission to the hospital have 
clinical relevance as they were associated with early coagulation abnormalities, 
complement activation and worse clinical outcome after severe trauma in humans. 
Although our study is observational, there are several lines of evidence indicating that 
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Ang-2 levels may play a critical role in the pathogenesis of an activated endothelium with 
increased vascular permeability observed early after trauma. For example, Parikh et al. 
showed that serum of septic patients with acute lung injury was able to disrupt the 
endothelial architecture in vitro, an effect that correlated with the serum levels of Ang-2. 
This effect could be reversed by adding Ang-1, thus increasing the Ang-1 signaling 
through the Tie-2 receptor.12 Furthermore, Bhandari et al. recently showed with Ang-2 
knockout and siRNA treated mice that Ang-2 is a key mediator responsible for the 
hyperoxia-induced acute lung injury.14 Despite these results, it should be pointed out that 
the development of organ failure in severely traumatized patients is multifactorial. 
Several factors have been identified including, but not limited to old age (>55 years), ISS 
>24 and transfusion of more than 6 units of blood.45,46 The data of our study confirm 
these findings, as trauma patients who later developed acute lung injury had a 
significantly higher blood transfusion requirement during the first 24 hours after 
admission to the hospital than those who did not develop lung dysfunction (data not 
shown). Interestingly, there seems to be a decrease in the incidence, severity and 
attendant mortality of post injury multiple organ failure over the last 10 years that is been 
attributed to improvement in trauma and critical care as well as the decreased use of 
blood transfusion during resuscitation.47 Taken together, these data indicate that Ang-2 
is not only a marker of endothelial activation and dysfunction, but may also have 
pathogenetic significance after severe trauma. 
In summary, we have shown that Ang-2 is being released early after trauma and that 
plasma levels of Ang-2 correlated with severity of injury and hypoperfusion in humans. 
High levels of Ang-2 were associated with coagulation abnormalities, increased 
complement activation and worse clinical outcome after major trauma, as it has been 
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previously reported for acute lung injury, cerebrovascular accidents, diabetic retinopathy 
and neoplasms.14,48-50 These findings indicate that Ang-2 may not only be a marker of 
endothelial cell activation but also be a mediator of injury and tissue edema. Further 
studies are required to define the exact role of Ang-2 after trauma and to determine 
whether interfering with the angiopoietin Tie-2 pathway could be therapeutically useful. 
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TABLES 
 
 
Table 1. Clinical characteristics of trauma patients. 
 
 
Demographic data 
Age, yrs  41 (27-63) 
Sex, Female / Male  n = 53 (25%) / n = 155 (75%) 
Characteristics on injury 
Injury Severity Score  17 (9-26) 
Penetrating injury  n = 53 (25%) 
Severe head injury (AIS head > 3) n = 59 (30%) 
Physiology 
Heart rate > 100 /min  n = 84 (41%) 
Systolic blood pressure <100 mmHg  n = 38 (18%) 
Base deficit > 6 mmol/l  n = 56 (27%) 
 
Total number of patients included is n = 208. Data are presented as median (inter-
quartile range) and numbers (%). 
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Table 2. The relationship of elevated Angiopoietin-2 levels to clinical outcome. 
 
 Odds Ratio (95% CI) P value 
 
 Mortality 4.0 (1.6-10.2) 0.001 
 Ventilator free days, ≤26 3.0 (1.5-5.7) <0.001 
 Acute lung injury 2.0 (0.8-4.7) 0.096 
 Acute renal failure 7.4 (2.7-20.7) <0.001 
 Transfusion, ≥2 Units of PRBC 2.7 (1.3-5.4) 0.003 
 
CI = confidence interval, PRBC = packed red blood cells. Normal range for Angiopoietin-
2 was 641-2755 pg/ml. Ventilator free days were calculated at 28 days. P-value: χ2 
analysis. 
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FIGURE LEGENDS 
 
Figure 1. Effects of injury on plasma levels of endothelial cell specific growth 
factors and von Willebrand factor. Blood samples were obtained from 208 
consecutive major trauma patients immediately upon admission to the hospital. Panels 
A-C. Plasma levels of Angiopoietin-2 (Ang-2), but not Angiopoietin-1 (Ang-1) and 
vascular endothelial growth factor (VEGF) correlated with the Injury Severity Score 
(ISS). Panel D. Plasma levels of von Willebrand factor (vWF), a marker of endothelial 
cell activation and dysfunction correlated with ISS. Data are presented in quartiles, *p ≤ 
0.05 compared with lowest quartile. 
Figure 2. Markers of endothelial activation and dysfunction. Panels A/B. Plasma 
levels of von Willebrand factor (vWF) and soluble thrombomodulin (sTM), markers of 
endothelial activation and dysfunction were measured in 208 trauma patients on 
admission to the hospital and correlated significantly with levels of Angiopoietin-2 (Ang-
2). Data are presented in quartiles, *p ≤ 0.05 compared with lowest quartile. 
Figure 3. Effects of systemic hypoperfusion on plasma levels of endothelial cell 
specific growth factors and von Willebrand factor. Blood samples were obtained 
from 208 consecutive major trauma patients immediately upon admission to the hospital. 
Panels A-C. Plasma levels of Angiopoietin-2 (Ang-2), but not Angiopoietin-1 (Ang-1) 
and vascular endothelial growth factor (VEGF) correlated with base deficit, a measure of 
the degree of tissue hypoperfusion. Panel D. Plasma levels of von Willebrand factor 
(vWF), a marker of endothelial cell activation and dysfunction correlated with base 
deficit. Data are presented in quartiles, *p ≤ 0.05 compared with lowest quartile. 
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Figure 4. High plasma levels of Angiopoietin-2 are associated with coagulation 
abnormalities in trauma patients. Panel A. Trauma patients with coagulation 
abnormalities (PT >15.2 sec, PTT >36.5 sec) had significantly higher levels of 
Angiopoietin-2 (Ang-2). *p ≤ 0.05. Panel B. Ang-2 levels rise as protein C levels 
decrease, suggesting activation of the anticoagulant protein C pathway in patients with 
increased endothelial activation. Panel C. High Ang-2 levels are related to increased 
fibrinolytic activity, expressed as levels of d-dimers. Data are presented in quartiles, *p ≤ 
0.05 compared with lowest quartile. 
Figure 5. Plasma levels of Angiopoietin-2 correlate with early complement 
activation in trauma patients. Panel A/B. High plasma Ang-2 levels are associated 
with increased complement activity. Bb fragments, a marker of the activation of the 
alternative complement pathway and soluble C5b-9 (MAC), generated during the late 
phase of complement activation were measured. Data are presented in quartiles, *p ≤ 
0.05 compared with lowest quartile. 
Figure 6. High plasma levels of Angiopoietin-2 are associated with increased 
mortality in patients with severe trauma. Panel A. Non-survivors after severe trauma 
have higher plasma levels of Angiopoietin-2 (Ang-2). Data are presented in quartiles, *p 
≤ 0.05 compared with lowest quartile. Panel B. Scatter-gram of individual values of Ang-
2 in survivors (n=183) and non-survivors (n=26) after major trauma; *p ≤ 0.05 compared 
with survivors.  
Figure 7. Schematic diagram of the proposed mechanism. Injury and 
hypoperfusion induce the extracellular release of Angiopoietin-2 by the vascular 
endothelium and activate the thrombomodulin-protein C pathway. Injury and 
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hypoperfusion cause the exocytosis of Weibel-Palade bodies (WPB) containing several 
inflammatory mediators including Angiopoietin-2 (Ang-2) and von Willebrand factor 
(vWF). Ang-2 binds to the same site of the Tie-2 receptor like Angiopoietin-1 (Ang-1) but 
functions as an antagonist ligand of Tie-2. Therefore, Ang-2 destabilizes blood vessels, 
enhances vascular leakage, induces vascular regression and primes the endothelium to 
respond to VEGF and other angiogenetic and inflammatory cytokines. vWF causes 
platelet activation and aggregation. Furthermore, injury and hypoperfusion activate the 
thrombomodulin-protein C pathway resulting in the de-activation of the coagulation 
Factors V and VIII and a de-repression of the fibrinolysis. T = thrombin, TM = 
thrombomodulin, PC = protein C, aPC = activated protein C, ePCR = endothelial protein 
C receptor. 
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